Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. (Q51503361)

6 April 2018

title

Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration. (English)

1 reference

6 April 2018

author

Juan M. Manzaneque

4

1 reference

6 April 2018

author name string

Navarro JF

1

1 reference

6 April 2018

Pedraza C

2

1 reference

6 April 2018

Martín M

3

1 reference

6 April 2018

Dávila G

5

1 reference

6 April 2018

Maldonado E

6

1 reference

6 April 2018

publication date

1 July 1998

1 reference

6 April 2018

Progress in Neuro-Psychopharmacology & Biological Psychiatry

published in

1 reference

6 April 2018

volume

22

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

835-844

1 reference

6 April 2018

gamma-Hydroxybutyric acid induced spike and wave discharges in rats: relation to high-affinity [3H]gamma-hydroxybutyric acid binding sites in the thalamus and cortex

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Actions of sulpiride and tiapride in a simple model of anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Pyretic action of low doses of gamma-hydroxybutyrate in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Sodium 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Gamma-hydroxybutyrate in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Acute and subchronic effects of tiapride on isolation-induced aggression in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

The catalepsy test: its ups and downs

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Gamma-Hydroxybutyrate Treatment of Schizophrenia: A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Anti-sedative and anti-cataleptic properties of NCS-382, a γ-hydroxybutyrate receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Tiapride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in geriatric agitation

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

Significance of gamma-hydroxybutyric acid in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

3'-5' cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900043-8

7 January 2021

10.1016/S0278-5846(98)00043-8

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

9723123

1 reference

6 April 2018